In a blog post, Kanteron noted that the offer is "at an early stage, therefore, there is no certainty as to whether, and under which conditions, Kanteron Systems may make a public tender offer to the shareholders of Agfa-Gevaert."
"Agfa HealthCare business unit revenues have been stagnant in the last few years," added Jorge Cortell, CEO of Kanteron Systems, in a statement. "However, a deal with Kanteron would allow Agfa to tap into our leading-edge technology, particularly in pathology and genomics, enabling Agfa to take the lead in the new clinical information systems for precision medicine market, which is a huge and disruptive long-term growth opportunity."
Kanteron Systems is a privately held company founded in 2005, according to its website. Its portfolio includes products for medical imaging, digital pathology, and clinical genomics. The company has offices in New York City, London, and Valencia, Spain.
As of press time, Agfa-Gevaert has not responded to a request for comment.
Copyright © 2018 AuntMinnieEurope.com